DANA REEVES: Open Payments
NPI 1699163964 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,033 in 50 payments from 15 companies in 2025. Trend: 2023 $1,033 · 2024 $1,026 · 2025 $1,033
Food & beverage: $1,033
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $335 |
| Incyte Corporation | 6 | $277 |
| Novartis Pharmaceuticals Corporation | 5 | $100 |
| Daiichi Sankyo Inc. | 3 | $70 |
| PFIZER INC. | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Merck Sharp & Dohme LLC | 2 | $33 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| SOBI, INC | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
Products named: EPKINLY, MONJUVI, Zynyz, KISQALI, VENCLEXTA, Enhertu, ELAHERE, KEYTRUDA.
Industry payments across AR — which companies pay providers there.
